Michelle Welsh - Alert Sample

Alert Sample

View the Parallel Parliament page for Michelle Welsh

Information between 2nd September 2025 - 22nd September 2025

Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.

Division Votes
2 Sep 2025 - English Devolution and Community Empowerment Bill - View Vote Context Michelle Welsh voted Aye - in line with the party majority and in line with the House One of 352 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 365 Noes - 164
2 Sep 2025 - English Devolution and Community Empowerment Bill - View Vote Context Michelle Welsh voted No - in line with the party majority and in line with the House One of 352 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 167 Noes - 367
15 Sep 2025 - Employment Rights Bill - View Vote Context Michelle Welsh voted Aye - in line with the party majority and in line with the House One of 303 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 314 Noes - 178
15 Sep 2025 - Employment Rights Bill - View Vote Context Michelle Welsh voted Aye - in line with the party majority and in line with the House One of 304 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 332 Noes - 160
15 Sep 2025 - Employment Rights Bill - View Vote Context Michelle Welsh voted Aye - in line with the party majority and in line with the House One of 300 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 326 Noes - 160
15 Sep 2025 - Employment Rights Bill - View Vote Context Michelle Welsh voted Aye - in line with the party majority and in line with the House One of 300 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 316 Noes - 172
15 Sep 2025 - Employment Rights Bill - View Vote Context Michelle Welsh voted Aye - in line with the party majority and in line with the House One of 300 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 330 Noes - 158
15 Sep 2025 - Employment Rights Bill - View Vote Context Michelle Welsh voted Aye - in line with the party majority and in line with the House One of 302 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 330 Noes - 161
15 Sep 2025 - Employment Rights Bill - View Vote Context Michelle Welsh voted Aye - in line with the party majority and in line with the House One of 302 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 330 Noes - 161
15 Sep 2025 - Employment Rights Bill - View Vote Context Michelle Welsh voted Aye - in line with the party majority and in line with the House One of 301 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 316 Noes - 161
15 Sep 2025 - Employment Rights Bill - View Vote Context Michelle Welsh voted Aye - in line with the party majority and in line with the House One of 300 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 328 Noes - 160
15 Sep 2025 - Employment Rights Bill - View Vote Context Michelle Welsh voted Aye - in line with the party majority and in line with the House One of 301 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 329 Noes - 163
15 Sep 2025 - Employment Rights Bill - View Vote Context Michelle Welsh voted Aye - in line with the party majority and in line with the House One of 302 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 318 Noes - 170
15 Sep 2025 - Employment Rights Bill - View Vote Context Michelle Welsh voted Aye - in line with the party majority and in line with the House One of 304 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 327 Noes - 164
16 Sep 2025 - Sentencing Bill - View Vote Context Michelle Welsh voted Aye - in line with the party majority and in line with the House One of 278 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 340 Noes - 77
16 Sep 2025 - Sentencing Bill - View Vote Context Michelle Welsh voted No - in line with the party majority and in line with the House One of 277 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 78 Noes - 292
9 Sep 2025 - Diego Garcia Military Base and British Indian Ocean Territory Bill - View Vote Context Michelle Welsh voted Aye - in line with the party majority and in line with the House One of 307 Labour Aye votes vs 1 Labour No votes Tally: Ayes - 330 Noes - 179
9 Sep 2025 - Diego Garcia Military Base and British Indian Ocean Territory Bill - View Vote Context Michelle Welsh voted No - in line with the party majority and in line with the House One of 314 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 116 Noes - 333
8 Sep 2025 - Renters’ Rights Bill - View Vote Context Michelle Welsh voted Aye - in line with the party majority and in line with the House One of 315 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 335 Noes - 160
8 Sep 2025 - Renters’ Rights Bill - View Vote Context Michelle Welsh voted Aye - in line with the party majority and in line with the House One of 316 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 325 Noes - 171
8 Sep 2025 - Renters’ Rights Bill - View Vote Context Michelle Welsh voted Aye - in line with the party majority and in line with the House One of 317 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 404 Noes - 98
8 Sep 2025 - Renters’ Rights Bill - View Vote Context Michelle Welsh voted Aye - in line with the party majority and in line with the House One of 314 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 336 Noes - 158
8 Sep 2025 - Renters’ Rights Bill - View Vote Context Michelle Welsh voted Aye - in line with the party majority and in line with the House One of 317 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 401 Noes - 96
8 Sep 2025 - Renters’ Rights Bill - View Vote Context Michelle Welsh voted Aye - in line with the party majority and in line with the House One of 319 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 402 Noes - 97
8 Sep 2025 - Renters’ Rights Bill - View Vote Context Michelle Welsh voted Aye - in line with the party majority and in line with the House One of 317 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 398 Noes - 93

Written Answers
Tirzepatide: Prices Asked by: Michelle Welsh (Labour - Sherwood Forest) Friday 12th September 2025 Question to the Department of Health and Social Care: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that tirzepatide remains at an affordable rate for people not prescribed the medication through the NHS. Answered by Karin Smyth - Minister of State (Department of Health and Social Care) As we shift the focus from treatment to prevention through our 10 Year Health Plan, we are determined to bring revolutionary modern treatments to everyone who needs them, not just those who can afford to pay. NHS England has worked with Eli Lilly to ensure that the list price increase will not affect National Health Service commissioning of tirzepatide in England as a treatment for eligible patients, and we remain committed to the rollout of this medicine as a weight loss treatment based on clinical priority. This will enable 220,000 eligible people to access the medication over the first three years. Not everyone who wants tirzepatide will be able to access it at first, and the initial eligibility criteria will be for people with a body mass index of 40 or more in addition to four or more qualifying comorbidities. Scotland, Wales, and Northern Ireland have also entered equivalent agreements to maintain their current commissioning approaches. Pricing in the private market is a matter for Eli Lilly and for private providers. Private patients who are impacted by price increases should discuss any concerns with their private provider. This includes their options regarding payment plans, alternative treatments, and/or stopping or tapering off their current medication. Eli Lilly is working with private providers to support continued patient access.
Tirzepatide: Prices Asked by: Michelle Welsh (Labour - Sherwood Forest) Friday 12th September 2025 Question to the Department of Health and Social Care: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of the price increase of mounjaro on people accessing weight loss medication. Answered by Karin Smyth - Minister of State (Department of Health and Social Care) As we shift the focus from treatment to prevention through our 10 Year Health Plan, we are determined to bring revolutionary modern treatments to everyone who needs them, not just those who can afford to pay. NHS England has worked with Eli Lilly to ensure that the list price increase will not affect National Health Service commissioning of tirzepatide in England as a treatment for eligible patients, and we remain committed to the rollout of this medicine as a weight loss treatment based on clinical priority. This will enable 220,000 eligible people to access the medication over the first three years. Not everyone who wants tirzepatide will be able to access it at first, and the initial eligibility criteria will be for people with a body mass index of 40 or more in addition to four or more qualifying comorbidities. Scotland, Wales, and Northern Ireland have also entered equivalent agreements to maintain their current commissioning approaches. Pricing in the private market is a matter for Eli Lilly and for private providers. Private patients who are impacted by price increases should discuss any concerns with their private provider. This includes their options regarding payment plans, alternative treatments, and/or stopping or tapering off their current medication. Eli Lilly is working with private providers to support continued patient access.

Written Answers

Tirzepatide: Prices
Asked by: Michelle Welsh (Labour - Sherwood Forest)
Friday 12th September 2025

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that tirzepatide remains at an affordable rate for people not prescribed the medication through the NHS.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

As we shift the focus from treatment to prevention through our 10 Year Health Plan, we are determined to bring revolutionary modern treatments to everyone who needs them, not just those who can afford to pay.

NHS England has worked with Eli Lilly to ensure that the list price increase will not affect National Health Service commissioning of tirzepatide in England as a treatment for eligible patients, and we remain committed to the rollout of this medicine as a weight loss treatment based on clinical priority. This will enable 220,000 eligible people to access the medication over the first three years. Not everyone who wants tirzepatide will be able to access it at first, and the initial eligibility criteria will be for people with a body mass index of 40 or more in addition to four or more qualifying comorbidities.

Scotland, Wales, and Northern Ireland have also entered equivalent agreements to maintain their current commissioning approaches.

Pricing in the private market is a matter for Eli Lilly and for private providers. Private patients who are impacted by price increases should discuss any concerns with their private provider. This includes their options regarding payment plans, alternative treatments, and/or stopping or tapering off their current medication. Eli Lilly is working with private providers to support continued patient access.

Tirzepatide: Prices
Asked by: Michelle Welsh (Labour - Sherwood Forest)
Friday 12th September 2025

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of the price increase of mounjaro on people accessing weight loss medication.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

Scotland, Wales, and Northern Ireland have also entered equivalent agreements to maintain their current commissioning approaches.

Michelle Welsh mentioned

Select Committee Documents
Friday 12th September 2025 Report - 3rd report - Appointment of the Registrar of Consultant Lobbyists Public Administration and Constitutional Affairs Committee Found: Richard Quigley (Labour; Isle of Wight West) Luke Taylor (Liberal Democrat; Sutton and Cheam) Michelle Welsh
Tuesday 9th September 2025 Attendance statistics - Members' attendance 2024–25 (Public Administration and Constitutional Affairs Committee), as at 23.7.25 Public Administration and Constitutional Affairs Committee Found: ) Luke Taylor (Liberal Democrat, Sutton and Cheam) (added 28 Oct 2024) 17 of 24 (70.8%) Michelle Welsh

Michelle Welsh - Select Committee Information

Calendar
Wednesday 10th September 2025 9:30 a.m. Public Administration and Constitutional Affairs Committee - Oral evidence Subject: Pre-appointment Hearing: Registrar of Consultant Lobbyists At 10:00am: Oral evidence Claire Bassett - The preferred candidate for the Registrar of Consultant Lobbyists View calendar - Add to calendar
Tuesday 9th September 2025 9:30 a.m. Public Administration and Constitutional Affairs Committee - Oral evidence Subject: The work of the UK Statistics Authority At 10:00am: Oral evidence Professor Sir Ian Diamond - Former National Statistician View calendar - Add to calendar
Wednesday 3rd December 2025 9:30 a.m. Public Accounts Commission - Private Meeting View calendar - Add to calendar
Tuesday 14th October 2025 9:30 a.m. Public Administration and Constitutional Affairs Committee - Oral evidence Subject: The work of the Registrar of Consultant Lobbyists At 10:00am: Oral evidence Harry Rich - Former Registrar of Consultant Lobbyists View calendar - Add to calendar

Select Committee Documents
Wednesday 3rd September 2025 Written Evidence - HM Government MIG0027 - Mission Government Mission Government - Public Administration and Constitutional Affairs Committee
Wednesday 3rd September 2025 Correspondence - Letter from Chancellor of the Duchy of Lancaster on UK Statistics Authority and Office for National Statistics, dated 22.7.25 Public Administration and Constitutional Affairs Committee
Wednesday 3rd September 2025 Correspondence - Letter from Chancellor of the Duchy of Lancaster on Propriety and ethics, dated 21.7.25 Public Administration and Constitutional Affairs Committee
Wednesday 3rd September 2025 Correspondence - Letter from Sir Robert Chote, Chair, UK Statistics Authority, and Catherine Little CB, Civil Service Chief Operating Officer and Cabinet Office Permanent Secretary on National Statistician Performance, dated 30.7.25 Public Administration and Constitutional Affairs Committee
Wednesday 3rd September 2025 Correspondence - Letter from Rt Hon. Nick Thomas-Symonds MP, Minister for the Cabinet Office and HM Paymaster General on Infected Blood Inquiry, dated 21.7.25 Public Administration and Constitutional Affairs Committee
Wednesday 3rd September 2025 Correspondence - Letter from Rt Hon Douglas Alexander MP, Minister of State at the Cabinet Office on Common Framework programme update, dated 17.7.25 Public Administration and Constitutional Affairs Committee
Wednesday 3rd September 2025 Correspondence - Letter from Ed Humpherson, Director General for Office for Statistics Regulation on State of the Statistical System report, dated 4.8.25 Public Administration and Constitutional Affairs Committee
Wednesday 3rd September 2025 Correspondence - Letter to Chancellor of the Duchy of Lancaster on UK Statistics Authority recruitment, dated 16.7.25 Public Administration and Constitutional Affairs Committee
Wednesday 3rd September 2025 Correspondence - Letter from Penny Young, Deputy Chair, UK Statistics Authority on follow-up after oral evidence on the work of the UK Statistics Authority, dated 21.8.25 Public Administration and Constitutional Affairs Committee
Wednesday 3rd September 2025 Correspondence - Letter from Emma Rourke, Acting National Statistician on follow-up after oral evidence on the work of the UK Statistics Authority, dated 21.8.25 Public Administration and Constitutional Affairs Committee
Wednesday 3rd September 2025 Oral Evidence - Jesse Norman Ministerial Statements and the Ministerial Code - Public Administration and Constitutional Affairs Committee
Tuesday 9th September 2025 Written Evidence - Local Government Association PEW0022 - Propriety, ethics and the wider standards landscape in the UK Propriety, ethics and the wider standards landscape in the UK - Public Administration and Constitutional Affairs Committee
Tuesday 9th September 2025 Written Evidence - Institute for Government PEW0012 - Propriety, ethics and the wider standards landscape in the UK Propriety, ethics and the wider standards landscape in the UK - Public Administration and Constitutional Affairs Committee
Tuesday 9th September 2025 Written Evidence - Institute of Regulation PEW0010 - Propriety, ethics and the wider standards landscape in the UK Propriety, ethics and the wider standards landscape in the UK - Public Administration and Constitutional Affairs Committee
Tuesday 9th September 2025 Written Evidence - The Constitution Society PEW0011 - Propriety, ethics and the wider standards landscape in the UK Propriety, ethics and the wider standards landscape in the UK - Public Administration and Constitutional Affairs Committee
Tuesday 9th September 2025 Written Evidence - Transparency International UK PEW0006 - Propriety, ethics and the wider standards landscape in the UK Propriety, ethics and the wider standards landscape in the UK - Public Administration and Constitutional Affairs Committee
Tuesday 9th September 2025 Written Evidence - Hleb Buziuk PEW0004 - Propriety, ethics and the wider standards landscape in the UK Propriety, ethics and the wider standards landscape in the UK - Public Administration and Constitutional Affairs Committee
Tuesday 9th September 2025 Written Evidence - Carnegie UK PEW0005 - Propriety, ethics and the wider standards landscape in the UK Propriety, ethics and the wider standards landscape in the UK - Public Administration and Constitutional Affairs Committee
Tuesday 9th September 2025 Written Evidence - Centre for British Democracy, King's College London, and Centre for British Democracy, King's College London PEW0021 - Propriety, ethics and the wider standards landscape in the UK Propriety, ethics and the wider standards landscape in the UK - Public Administration and Constitutional Affairs Committee
Tuesday 9th September 2025 Written Evidence - UK Government - Cabinet Office PEW0020 - Propriety, ethics and the wider standards landscape in the UK Propriety, ethics and the wider standards landscape in the UK - Public Administration and Constitutional Affairs Committee
Tuesday 9th September 2025 Written Evidence - University of Bristol & Bangor University PEW0015 - Propriety, ethics and the wider standards landscape in the UK Propriety, ethics and the wider standards landscape in the UK - Public Administration and Constitutional Affairs Committee
Tuesday 9th September 2025 Written Evidence - Dr Ben Worthy, Dr Michele Crepaz, and Dr Stefani Langehennig PEW0007 - Propriety, ethics and the wider standards landscape in the UK Propriety, ethics and the wider standards landscape in the UK - Public Administration and Constitutional Affairs Committee
Tuesday 9th September 2025 Written Evidence - Information Commissioner's Office PEW0009 - Propriety, ethics and the wider standards landscape in the UK Propriety, ethics and the wider standards landscape in the UK - Public Administration and Constitutional Affairs Committee
Tuesday 9th September 2025 Written Evidence - Chartered Institute of Public Relation (CIPR) PEW0017 - Propriety, ethics and the wider standards landscape in the UK Propriety, ethics and the wider standards landscape in the UK - Public Administration and Constitutional Affairs Committee
Tuesday 9th September 2025 Written Evidence - Unlock Democracy PEW0018 - Propriety, ethics and the wider standards landscape in the UK Propriety, ethics and the wider standards landscape in the UK - Public Administration and Constitutional Affairs Committee
Tuesday 9th September 2025 Written Evidence - University of Bristol PEW0016 - Propriety, ethics and the wider standards landscape in the UK Propriety, ethics and the wider standards landscape in the UK - Public Administration and Constitutional Affairs Committee
Tuesday 9th September 2025 Written Evidence - TIRN (Transgression International Research Network) PEW0013 - Propriety, ethics and the wider standards landscape in the UK Propriety, ethics and the wider standards landscape in the UK - Public Administration and Constitutional Affairs Committee
Tuesday 9th September 2025 Written Evidence - Spotlight on Corruption PEW0025 - Propriety, ethics and the wider standards landscape in the UK Propriety, ethics and the wider standards landscape in the UK - Public Administration and Constitutional Affairs Committee
Tuesday 9th September 2025 Written Evidence - Royal Statistical Society PEW0023 - Propriety, ethics and the wider standards landscape in the UK Propriety, ethics and the wider standards landscape in the UK - Public Administration and Constitutional Affairs Committee
Tuesday 9th September 2025 Written Evidence - Louise Edwards PEW0019 - Propriety, ethics and the wider standards landscape in the UK Propriety, ethics and the wider standards landscape in the UK - Public Administration and Constitutional Affairs Committee
Tuesday 9th September 2025 Written Evidence - Office of the Registrar of Consultant Lobbyists PEW0003 - Propriety, ethics and the wider standards landscape in the UK Propriety, ethics and the wider standards landscape in the UK - Public Administration and Constitutional Affairs Committee
Tuesday 9th September 2025 Attendance statistics - Members' attendance 2024–25 (Public Administration and Constitutional Affairs Committee), as at 23.7.25 Public Administration and Constitutional Affairs Committee
Tuesday 9th September 2025 Oral Evidence - Professor Sir Ian Diamond The work of the UK Statistics Authority - Public Administration and Constitutional Affairs Committee
Wednesday 10th September 2025 Oral Evidence - Claire Bassett Public Administration and Constitutional Affairs Committee
Friday 12th September 2025 Report - 3rd report - Appointment of the Registrar of Consultant Lobbyists Public Administration and Constitutional Affairs Committee

Select Committee Inquiry
19 Sep 2025 NAO Annual Report 2024-25 and Supplementary Estimate 2024-25 Public Accounts Commission Committee (Other) Not accepting submissions No description available